A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Clinical trial NCT06973187 · RECRUITING
Trial details
- NCT number
- NCT06973187
- Sponsor
- BeOne Medicines
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-04
- Primary completion
- 2028-04-17
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.